VERA
VERA THERAPEUTICS INC
Latest close $30.23 as of Aug 5, 2026
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro.
Compare plans.
Beneficial ownership filing history
Showing 3 of 5 parsed filing(s) · 2 older require more history access| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| BlackRock CIK0002012383 | Jun 30, 2026 observed Jul 30, 2026 filed · 30d Schedule 13G amendment | Earliest Schedule 13G amendment found | 5.3M | 12.00% | $42.91 | $33.05 | $30.23 |
| T. Rowe Price Associates CIK0000080255 | Mar 31, 2026 observed May 15, 2026 filed · 45d Schedule 13G amendment | Reported reduction | 4.6M -888.3K | 12.00% 0.00 pts | $40.23 | $37.32 | $30.23 |
| Vanguard Group CIK0000102909 | Mar 13, 2026 observed Mar 27, 2026 filed · 14d Schedule 13G amendment | Earliest Schedule 13G amendment found | 11 | 12.00% | $39.96 | $38.86 | $30.23 |